Cargando…
Novel starting points for fragment-based drug design against mycobacterial thioredoxin reductase identified using crystallographic fragment screening
The increasing number of people dying from tuberculosis and the existence of extensively drug-resistant strains has led to an urgent need for new antituberculotic drugs with alternative modes of action. As part of the thioredoxin system, thioredoxin reductase (TrxR) is essential for the survival of...
Autores principales: | Füsser, Friederike T., Wollenhaupt, Jan, Weiss, Manfred S., Kümmel, Daniel, Koch, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478635/ https://www.ncbi.nlm.nih.gov/pubmed/37574972 http://dx.doi.org/10.1107/S2059798323005223 |
Ejemplares similares
-
Of problems and opportunities—How to treat and how to not treat crystallographic fragment screening data
por: Weiss, Manfred S., et al.
Publicado: (2022) -
FragMAXapp: crystallographic fragment-screening data-analysis and project-management system
por: Lima, Gustavo M. A., et al.
Publicado: (2021) -
Frag4Lead: growing crystallographic fragment hits by catalog using fragment-guided template docking
por: Metz, Alexander, et al.
Publicado: (2021) -
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
por: Douangamath, Alice, et al.
Publicado: (2020) -
Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking
por: Schuller, Marion, et al.
Publicado: (2021)